Cargando…

Metabolic Factors Associated with Risk of Renal Cell Carcinoma

Previous studies have shown that obesity and hypertension are associated with increased risk of renal cell carcinoma (RCC), but less is known about the association to other metabolic factors. In the Metabolic Syndrome and Cancer project (Me-Can) data on body mass index (BMI, kg/m2), blood pressure,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Häggström, Christel, Rapp, Kilian, Stocks, Tanja, Manjer, Jonas, Bjørge, Tone, Ulmer, Hanno, Engeland, Anders, Almqvist, Martin, Concin, Hans, Selmer, Randi, Ljungberg, Börje, Tretli, Steinar, Nagel, Gabriele, Hallmans, Göran, Jonsson, Håkan, Stattin, Pär
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585341/ https://www.ncbi.nlm.nih.gov/pubmed/23468995 http://dx.doi.org/10.1371/journal.pone.0057475

Ejemplares similares

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma
por: Häggström, Christel, et al.
Publicado: (2013)

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
por: Häggström, Christel, et al.
Publicado: (2014)

Metabolic risk score and cancer risk: pooled analysis of seven cohorts
por: Stocks, Tanja, et al.
Publicado: (2015)

Pooled cohort study on height and risk of cancer and cancer death
por: Wirén, Sara, et al.
Publicado: (2013)

Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580 000 subjects within the Me-Can project
por: Lindkvist, Björn, et al.
Publicado: (2014)

Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
por: Stocks, Tanja, et al.
Publicado: (2009)

Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can)
por: Strohmaier, Susanne, et al.
Publicado: (2013)

A Prospective Study on Metabolic Risk Factors and Gallbladder Cancer in the Metabolic Syndrome and Cancer (Me-Can) Collaborative Study
por: Borena, Wegene, et al.
Publicado: (2014)

Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)
por: Stocks, Tanja, et al.
Publicado: (2010)

Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
por: Sun, Ming, et al.
Publicado: (2023)

Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria
por: Van Hemelrijck, Mieke, et al.
Publicado: (2018)

Interaction of leisure‐time physical activity with body mass index on the risk of obesity‐related cancers: A pooled study
por: Sun, Ming, et al.
Publicado: (2022)

Changes of Body Mass Index in Relation to Mortality: Results of a Cohort of 42,099 Adults
por: Klenk, Jochen, et al.
Publicado: (2014)

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
por: Jochems, Sylvia H. J., et al.
Publicado: (2023)

Blood pressure and falls in community-dwelling people aged 60 years and older in the VHM&PP cohort
por: Klein, Diana, et al.
Publicado: (2013)

Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women
por: Bjørge, T, et al.
Publicado: (2005)

Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
por: Engeland, A, et al.
Publicado: (2003)

Reply: Height, body mass index, and prostate cancer – a follow-up of 950 000 Norwegian men
por: Engeland, A, et al.
Publicado: (2004)

Metabolic factors and hip fracture risk in a large Austrian cohort study
por: Dominic, Erlangga, et al.
Publicado: (2020)

Waist circumference and a body shape index and prostate cancer risk and mortality
por: Jochems, Sylvia H. J., et al.
Publicado: (2021)

Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study
por: Bjørge, T, et al.
Publicado: (2008)

γ-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors – A Pooled Cohort Analysis
por: Preyer, Oliver, et al.
Publicado: (2016)

Body size and thyroid cancer in two million Norwegian men and women
por: Engeland, A, et al.
Publicado: (2006)

Associations between prediagnostic blood glucose levels, diabetes, and glioma
por: Schwartzbaum, Judith, et al.
Publicado: (2017)

Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study
por: Bjørge, Tone, et al.
Publicado: (2016)

Paternal characteristics associated with maternal periconceptional use of folic acid supplementation
por: Mortensen, Jan Helge Seglem, et al.
Publicado: (2018)

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study
por: Tomic, Katarina, et al.
Publicado: (2018)

Prostate specific antigen for early detection of prostate cancer: longitudinal study
por: Holmström, Benny, et al.
Publicado: (2009)

Supplemental folic acid in pregnancy and childhood cancer risk
por: Mortensen, Jan Helge Seglem, et al.
Publicado: (2016)

Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study
por: Sköld, Camilla, et al.
Publicado: (2020)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Serum triglyceride concentrations and cancer risk in a large cohort study in Austria
por: Ulmer, H, et al.
Publicado: (2009)

The relative risk of second primary cancers in Austria’s western states: a retrospective cohort study
por: Preyer, Oliver, et al.
Publicado: (2017)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
por: Thomasson, Marcus, et al.
Publicado: (2012)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus
por: Häggström, Christel, et al.
Publicado: (2018)

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
por: Beckmann, Kerri, et al.
Publicado: (2019)

Association between medical androgen deprivation therapy and long‐term cardiovascular disease and all‐cause mortality in nonmetastatic prostate cancer
por: Forster, Rachel B., et al.
Publicado: (2022)

The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults
por: Fritz, Josef, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rhp9oo2nn8e1h6gqau86qgneqi